Supervisory Board of Unibail-Rodamco-Westfield SE (URW) to propose Jacques Richier as next Chairman of the Supervisory Board at the URW 2023 General Meeting
Paris, Amsterdam, March 9, 2023
Supervisory Board of Unibail-Rodamco-Westfield SE (URW) to proposeJacquesRichier as next Chairman of the Supervisory Board at the URW 2023 General Meeting
Unibail-Rodamco-Westfield SE (URW) announces that its Supervisory Board has selected Jacques Richier as its candidate for new Supervisory Board Member to be proposed at the 2023 Annual General Meeting (AGM) on May 11, 2023. Subject to his appointment, Jacques Richier will assume chairmanship of the Supervisory Board at the conclusion of the meeting, for a 3-year mandate.
A French national, Jacques Richier, 68 years old, is currently the Chairman of the Board of Directors at Allianz France (former AGF), a subsidiary of Allianz S.E., one of the world’s largest asset managers and world leading insurers.
The proposal follows a thorough selection process led by Roderick Munsters, Chairman of the Governance, Nomination & Remuneration Committee and Cécile Cabanis, Vice-Chair of the Supervisory Board to propose a successor for Léon Bressler, who has reached the statutory age limit under article 13.4 of the
Unibail-Rodamco-Westfield SE articles of association and will end his tenure as Chairman and member of the Supervisory Board at the 2023 AGM.
For further information, please contact:
VP, Chief of Staff to the CEO
+1 424 303 1948
Cornelia Schnepf – Finelk
+44 7387 108 998
Sonia Fellmann – PLEAD
+33 6 27 84 91 30
Molly Morse – Kekst CNC
+ 1 212 521 4826
Unibail-Rodamco-Westfield is an owner, developer and operator of sustainable, high-quality real estate assets in the most dynamic cities in Europe and the United States.
The Group operates 78 shopping centres in 12 countries, including 43 which carry the iconic Westfield brand. These centres attract over 900 million visits annually and provide a unique platform for retailers and brands to connect with consumers. URW also has a portfolio of high-quality offices, 10 convention and exhibition venues in Paris, and a €3 Bn development pipeline of mainly mixed-use assets. Currently, its €52 Bn portfolio is 87% in retail, 6% in offices, 5% in convention and exhibition venues, and 2% in services (as at December 31, 2022).
URW is a committed partner to major cities on urban regeneration projects, through both mixed-use development and the retrofitting of buildings to industry-leading sustainability standards. These commitments are enhanced by the Group’s Better Places 2030 agenda, which strives to make a positive environmental, social and economic impact on the cities and communities where URW operates.
URW’s stapled shares are listed on Euronext Amsterdam and Euronext Paris (Ticker: URW), with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from a BBB+ rating from Standard & Poor’s and from a Baa2 rating from Moody’s.
For more information, please visit www.urw.com
- Supervisory Board of Unibail-Rodamco-Westfield SE (URW) to propose Jacques Richier as next Chairman at the URW 2023 General Meeting
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Fortuna files Form 40-F, Annual Report30.3.2023 23:15:00 CEST | Press release
VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that the Company has filed today its fiscal 2022 annual report on Form 40-F with the U.S. Securities and Exchange Commission (“SEC”). The Form 40-F, which includes the Company’s fiscal 2022 annual audited financial statements, management’s discussion and analysis, and annual information form, is available on the Company’s website and on the SEC´s website. Printed copies of the annual financial statements are available free of charge to Fortuna shareholders upon written request. About Fortuna Silver Mines Inc. Fortuna Silver Mines Inc. is a Canadian precious metals mining company with four operating mines in Argentina, Burkina Faso, Mexico and Peru, and a fifth mine under construction in Côte d'Ivoire. Sustainability is integral to all our operations and relationships. We produce gold and silver and generate shared value over the long-term for our stakeholders through
Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet")30.3.2023 23:13:48 CEST | pressemeddelelse
Pharma Equity Group A/S Selskabsmeddelelse Årets meddelelse nr.: 24 Dato: 30. marts 2023 Samlede antal stemmerettigheder og aktiekapital i Pharma Equity Group A/S ("Selskabet") I henhold til Lov om kapitalmarkeder (lovbekendtgørelse nr. 41 af 13. januar 2023) § 32 offentliggør Selskabet hermed det samlede antal stemmerettigheder og den samlede aktiekapital i Selskabet. Efter kapitalforhøjelse registreret den 24. marts 2023 vedrørende udstedelse af vederlagsaktier til aktionærerne i Reponex Pharmaceuticals A/S og nye aktier med fortegningsret for Selskabets eksisterende aktionærer i en fortegningsretsemission, hvor Selskabet i alt udstedte 978.584.263 stk. nye aktier à nominelt DKK 1,00 pr. aktie, udgør Selskabets samlede nominelle aktiekapital DKK 1.022.963.883 svarende til 1.022.963.883 antal aktier og 1.022.963.883 stemmer pr. 31. marts 2023 Yderligere information Alle henvendelser vedrørende ovenstående bedes venligst rettet til direktør Peter Ole Jensen på e-mailadressen: peter.ole
Multitude Group Annual Report for 2022 published30.3.2023 22:45:00 CEST | Press release
Multitude Group Annual Report for 2022 published Helsinki, 30 March 2023 – Multitude SE (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude” or the “Group”) is pleased to announce that the Group's Annual Report, Corporate Governance Statement and Remuneration Report for the year ended 31 December 2022 have been published today on the company’s website. The Annual Report consists of annual review and financial review, including Board of Directors‘ report, consolidated financial statements and parent company’s financial statements. The annual review includes the ESG Report 2022 which comprises the non-financial statement. It outlines the Group’s ESG Goals and KPIs focused on people, processes, and the environment, with commencement of reporting on the Group’s carbon emissions. The ESG report 2022 further highlights the Group’s commitment to customer well-being through responsible lending practices and the introduction of a Responsible Lending Index and a commitment to progress on employee well
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion30.3.2023 22:45:00 CEST | Press release
Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT; ANY PUBLIC OFFERING OF SUCH SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM THE ISSUER, WHICH WOULD CONTAIN DETAILED INFORMATION ABOUT THE COMPANY AND MANAGEMENT, AS WELL AS FINANCIAL STATEMENTS. As announced on 30 March 2023, Zealand Pharma commenced
Multitude SE: Notice to Convene Multitude SE's Annual General Meeting of Shareholders30.3.2023 22:45:00 CEST | Press release
NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS Notice is given to the shareholders of Multitude SE (Company) that the Annual General Meeting of the Company is to be held on 27 April 2023 at 10:00 a.m. (EEST / Finnish time) at the offices of Castrén & Snellman Attorneys Ltd, Eteläesplanadi 14, Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will start at 9:30 a.m. (EEST / Finnish time). Shareholders may also exercise their voting rights by voting in advance. Instructions concerning advance voting are provided in Section 3.4 of this notice. It will not be possible to participate in the meeting or follow the meeting via an online stream or otherwise in real time by the use of telecommunication connections or technical means. The meeting will be held in the English language. 1 MATTERS ON THE AGENDA OF THE GENERAL MEETING OF SHAREHOLDERS At the General Meeting of Shareholders, the following matte